-
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts
来源: Buzz FX / 01 11月 2024 03:08:16 America/New_York
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts Written by MarketBeat November 1, 2024 Share Link copied to clipboard. Shares of Immunome, Inc. ( NASDAQ:IMNM - Get Free Report ) have received an average recommendati
Read more...